BMC Cost Effectiveness and Resource Allocation
(Accessed 26 August 2017)
Cost-effectiveness analysis of a universal mass vaccination program with a PHiD-CV 2+1 schedule in Malaysia
Xiao Jun Wang, Ashwini Saha and Xu-Hao Zhang
Published on: 22 August 2017
A PHiD-CV 2+1 universal mass vaccination program could substantially reduce pneumococcal disease burden versus no vaccination, and was expected to be cost-effective in Malaysia. A PHiD-CV 2+1 program was also expected to be a dominant choice over a PCV13 2+1 program in Malaysia.